Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: The Role of Nuclear Factor κB Activation in the Development of Renal Fibrosis
Tài liệu tham khảo
10.1046/j.1523-1755.1998.00079.x
2 Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071.
3 Burdmann EA, Andoh TF, Lindsley J, Houghton DC, Bennett WM. Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity. Nephrol Dial Transplant. 1994;9:16–21.
4 Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int. 1996;50:1110–1117.
5 Rob PM, Lebeau A, Nobiling R, Schmid H, Bley N, Dick K, et al. Magnesium metabolism: basic aspects and implications of ciclosporine toxicity in rats. Nephron. 1996;72:59–66.
10.1046/j.1523-1755.2000.00429.x
7 Miura K, Nakatani T, Asai T, Yamanaka S, Tamada S, Tashiro K, et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation. 2002;73:340–347.
8 Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, et al. Magnesium supplementation prevents experimental chronic cyclosporine A nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation. 2002;74:784–791.
9 Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991;39:550–556.
10.1097/01.TP.0000057242.96219.AF
10.1046/j.1523-1755.2003.00714.x
10.1146/annurev.immunol.14.1.649
1996, 16, 1295, 10.1128/MCB.16.4.1295
10.1016/S0092-8674(00)81064-8
10.1007/BF00870378
10.1254/jjp.90.361
17 Tashiro K, Tamada S, Kuwabara N, Komiya T, Takekida K, Asai T, et al. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor κB. Int J Mol Med. 2003;12:587–592.
18 Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, et al. Role for “uremic toxin” in the progressive loss of intact nephrons in chronic renal failure. Kidney Int. 1991;40:461–469.
19 Niwa T, Miyazaki T, Hashimoto N, Hayashi H, Ise M, Uehara Y, et al. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats. Am J Nephrol. 1992;12:201–206.
20 Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron. 1992;62:305–314.
10.1046/j.1523-1755.2003.00906.x